See what members are saying about muscular dystrophy treatments, the side effects to expect, and the drug basics.
All treatment information is medically reviewed · February 17, 2026
Overview
Emflaza is approved by the U.S. Food and Drug Administration (FDA) for the treatment of Duchenne muscular dystrophy (DMD) in people 2 years of age and older. It is specifically indicated for use in children and…
Overview
Vyondys 53, approved by the U.S. Food and Drug Administration (FDA), is used to treat Duchenne muscular dystrophy (DMD) in people with a confirmed mutation (variation) of the DMD gene that allows for exon 53…
Become a member to get even more